News
-
-
-
PRESS RELEASE
Strong EBITDA growth: Cantourage Group SE posts EBITDA of EUR 1.4 million in third quarter of 2024 and sets course for further profitable growth
Cantourage Group SE achieves strong EBITDA growth of EUR 1.4 million in Q3 2024, with sales reaching EUR 30.2 million, continuing positive trend -
-
-
-
-
-
-
PRESS RELEASE
The medical cannabis market is booming: Cantourage Group SE reports record quarter in third quarter of 2024
Cantourage Group SE reports record sales quarter in Q3 2024, with revenue soaring to EUR 13.2 million and EBITDA of EUR 0.9-1.1 million. Strong growth expected for full year 2024